JIC Venture Growth Investments — 2023 Investments
2 investments dated 2023 · listed companies and verified rows first · show all
GITAI develops robotic technologies for space exploration, specializing in robotic solutions for the construction and maintenance of satellites, lunar settlements, and planetary infrastructure.
Deep TechMobility & TransportationRoboticsSpace TechTorrance, JP
Sho Nakanose(Executive Officer, Director, Promoter)Tatsuro KoyamaToyotaka Kozuki(Director)Yuta Kimura(Director)
Co-investors500 GlobalCoral CapitalDBJ CapitalGlobal BrainKDDI Open Innovation FundSkyland Ventures
PRD Therapeutics is a drug-discovery startup developing first-in-class oral SOAT2-selective inhibitors (PRD compounds derived from pyripyropene A) to regulate lipid metabolism.
BiotechLongevityTokyo, JP
細田 莞爾(代表取締役社長 / President & Co-Founder)供田 洋(社外取締役 / Co-Founder)
Co-investorsJAFCO GroupMizuho CapitalSMBC Venture Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.